Last reviewed · How we verify
Migraine Relief — Competitive Intelligence Brief
marketed
Trigeminal nerve
Neurology
Small molecule
Live · refreshed every 30 min
Target snapshot
Migraine Relief (Migraine Relief) — Theranica. Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Migraine Relief TARGET | Migraine Relief | Theranica | marketed | Trigeminal nerve |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Migraine Relief CI watch — RSS
- Migraine Relief CI watch — Atom
- Migraine Relief CI watch — JSON
- Migraine Relief alone — RSS
Cite this brief
Drug Landscape (2026). Migraine Relief — Competitive Intelligence Brief. https://druglandscape.com/ci/migraine-relief. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing